Viyash Scientific Limited has informed the Exchange regarding a press release dated May 19, 2026, titled "Press Release for quarter and year ended 31 March 2026".
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Viyash Scientific reported its strongest quarter ever, with Q4 FY26 revenue of ₹9,200 million (up 19.1%) and EBITDA of ₹2,001 million (up 63.8%). Full-year FY26 revenue stood at ₹34,203 million (up 13.8%) and EBITDA at ₹7,025 million (up 59.6%), with PAT surging to ₹2,246 million (up 1,324%). The company credited this to successful integration of facilities and operations, improved operating leverage, and disciplined cost controls amid geopolitical disruptions. Net Debt/EBITDA is a very comfortable 0.2x, and the balance sheet is significantly deleveraged.
Strong operational performance and clean balance sheet are positive signals for investors. The company also flagged active evaluation of selective inorganic (M&A) opportunities, which could drive further growth beyond organic expansion.